Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

905 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sandostatin LAR in acromegalic patients: a dose-range study.
Fløgstad AK, Halse J, Haldorsen T, Lancranjan I, Marbach P, Bruns C, Jervell J. Fløgstad AK, et al. Among authors: bruns c. J Clin Endocrinol Metab. 1995 Dec;80(12):3601-7. doi: 10.1210/jcem.80.12.8530606. J Clin Endocrinol Metab. 1995. PMID: 8530606 Clinical Trial.
Sandostatin LAR in acromegalic patients: long-term treatment.
Fløgstad AK, Halse J, Bakke S, Lancranjan I, Marbach P, Bruns C, Jervell J. Fløgstad AK, et al. Among authors: bruns c. J Clin Endocrinol Metab. 1997 Jan;82(1):23-8. doi: 10.1210/jcem.82.1.3572. J Clin Endocrinol Metab. 1997. PMID: 8989226
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.
van der Hoek J, de Herder WW, Feelders RA, van der Lely AJ, Uitterlinden P, Boerlin V, Bruns C, Poon KW, Lewis I, Weckbecker G, Krahnke T, Hofland LJ, Lamberts SW. van der Hoek J, et al. Among authors: bruns c. J Clin Endocrinol Metab. 2004 Feb;89(2):638-45. doi: 10.1210/jc.2003-031052. J Clin Endocrinol Metab. 2004. PMID: 14764775 Free article. Clinical Trial.
Discovery and development of somatostatin agonists.
Marbach P, Bauer W, Bodmer D, Briner U, Bruns C, Kay A, Lancranjan I, Pless J, Raulf F, Robison R, Sharkey J, Soranno T, Stolz B, Vit P, Weckbecker G. Marbach P, et al. Among authors: bruns c. Pharm Biotechnol. 1998;11:183-209. doi: 10.1007/0-306-47384-4_9. Pharm Biotechnol. 1998. PMID: 9760681 No abstract available.
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ, van der Hoek J, van Koetsveld PM, de Herder WW, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, Feelders R, van der Lely AJ, Beckers A, Lamberts SW. Hofland LJ, et al. Among authors: bruns c. J Clin Endocrinol Metab. 2004 Apr;89(4):1577-85. doi: 10.1210/jc.2003-031344. J Clin Endocrinol Metab. 2004. PMID: 15070915 Free article.
905 results